Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy
This affects how GLP-1 medications distribute, are metabolized, and produce their weight-management and glucose-control effects
doi: 10.1016/j.ebiom.2018.06.005 Summary Keywords tubular injury, diabetic kidney disease, mechanism, therapy, programmed cell death, stem cell Citation Wang Y, Jin M, Cheng CK and Li Q (2023) Tubular injury in diabetic kidney disease: molecular mechanisms and potential therapeutic perspectives
Some people might develop a receptor resistance to the hormone in GLP-1s, he says
Yet, Vit B12 deficiency and HHcy are both catalysts for a singular non-motor PD phenotype characterized with cognitive dysfunction
When researchers measured milk levels, they used mothers taking injectable forms